上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™

Gibco™ Opti-MEM™ I Reduced Serum Medium, GlutaMAX™ Supplement

Opti-MEM™ I medium can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts.                                                                                                      Using Opti-MEM™ I Medium：

Opti-MEM™ I Reduced-Serum Medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.

cGMP manufacturing and quality system：

Opti-MEM™ I is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Opti-MEM™ I product made in our Scotland facility (51985-042). This facility is also registered with the FDA as a medical device manufacturer and certified to the ISO 13485 standard.

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ Reduced Serum Medium, powder ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ Reduced Serum Medium, powder

Gibco™ Opti-MEM™ Reduced Serum Medium, powder

Gibco™ Opti-MEM™ is a unique media that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%.

cGMP Manufacturing and Quality System：

For supply chain continuity, we manufacture Gibco™ Opti-MEM™ at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.

Gibco™ Opti-MEM™ uses a sodium bicarbonate buffer system (2.4 g/L) and therefore requires a 5-10% CO2 environment to maintain physiological pH.

Powder forms of Gibco™ cell culture medium require sodium bicarbonate supplementation, pH adjustment and filtration at the time of preparation

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol

Gibco™ Opti-MEM™ I Reduced Serum Medium, no phenol red

Opti-MEM™ I medium can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts.                                                                                                       Using Opti-MEM™ Reduced-Serum Medium：

Opti-MEM™ I medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.

cGMP manufacturing and quality system：

For supply chain continuity, we manufacture Opti-MEM™ Reduced-Serum Medium at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.

上海金畔生物科技有限公司提供Gibco™ Opti-MEM™|Reduced Serum Medium ，欢迎访问官网了解更多产品信息和订购。
Gibco™ Opti-MEM™|Reduced Serum Medium

Gibco™ Opti-MEM™|Reduced Serum Medium

Using Opti-MEM™ I Medium：

Opti-MEM™ I Reduced-Serum Medium is a unique medium that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%. Opti-MEM™ I medium uses a sodium bicarbonate buffer system (2.4 g/L), and therefore requires a 5–10% CO2 environment to maintain physiological pH.

cGMP manufacturing and quality system：

Opti-MEM™ I is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards. For supply chain continuity, we offer an identical Opti-MEM™ I product made in our Scotland facility (31985-047). This facility is also registered with the FDA as a medical device manufacturer and certified to the ISO 13485 standard.